Development and evaluation of a pharmaceutical care program to reduce modifiable risk of chronic complications in brazilian type 2 diabetic patients
Artículo
Acceso abierto
Artículo
SEDICI UNLP
In this study we developed and evaluated a pharmaceutical care program (PCP) to reduce
modifiable risk factors of chronic complications of type 2 diabetes. Patients who acquired their anti-diabetic
drugs from a Brazili...
Idioma en
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access